Officials at GE Healthcare (NYSE:GE) filed a lawsuit against one of their Waukesha, Wisc., engineers after finding out that he copied millions of sensitive files that the company says were not necessary for his role.
GE Healthcare
Breast cancer: GE Healthcare wins pivotal FDA approval for 3D breast imaging
Imaging giant GE Healthcare (NYSE:GE) won FDA approval for its 3D breast tomosynthesis imaging system, MassDevice.com has learned.
GE Healthcare plans to move its life sciences HQ from Jersey to Mass.
Abbott CEO chides critics of corporate inversions | Medtech Wall Street news for the week of July 21, 2014
GE Healthcare idles for another quarter
GE Healthcare (NYSE:GE) isn’t terribly optimistic about its prospects for the rest of this year as its 2nd-quarter earnings report again shows softness in the U.S. dragging down total healthcare activity.
GE Healthcare reorganizes after losing another to Medtronic | MassDevice.com On Call
Press Release: GE Healthcare Announces FDA Approval of Invenia Automated Breast Ultrasound System
GE Healthcare wins FDA approval for dense-breast mammograms
GE Healthcare (NYSE:GE) announced this week that it won FDA approval for its Invenia Automated Breast Ultrasound system, indicated to help doctors identify cancers in women with dense breast tissue.
Animals in labs: PETA’s long history with the medtech industry
Animal rights activists have long raised concerns about some of the largest medical device companies, taking up minuscule stock holdings to gain access to shareholder meetings at a raft of medtech makers.
GE’s new cybersecurity buy includes medical devices | MassDevice.com On Call
GE Healthcare’s new Vizamyl Alzheimer’s disease detector comes to the U.S.
GE Healthcare’s (NYSE:GE) newly FDA-approved Vizamyl imaging agent is about to make its initial appearance in 7 U.S. markets, where doctors can use it to help diagnose patients with Alzheimer’s disease and dementia.